BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 107 filers reported holding BIOXCEL THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20 | -85.2% | 8,082 | +11.0% | 0.00% | – |
| Q1 2023 | $135 | +150.0% | 7,284 | +188.6% | 0.00% | – |
| Q4 2022 | $54 | -100.0% | 2,524 | -85.7% | 0.00% | – |
| Q1 2022 | $367,000 | +841.0% | 17,598 | +806.2% | 0.00% | – |
| Q4 2021 | $39,000 | +25.8% | 1,942 | +76.1% | 0.00% | – |
| Q3 2021 | $31,000 | +6.9% | 1,103 | +8.7% | 0.00% | – |
| Q2 2021 | $29,000 | -66.7% | 1,015 | -49.8% | 0.00% | – |
| Q1 2021 | $87,000 | – | 2,020 | -38.2% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 3,268 | -89.6% | 0.00% | -100.0% |
| Q2 2020 | $1,663,000 | +75.1% | 31,372 | -26.3% | 0.00% | +50.0% |
| Q1 2020 | $950,000 | – | 42,547 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |